Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
Approach to investigating a patient with hematuria to exclude bladder cancer:
- Refer patients aged 45 years and over with unexplained visible hematuria without urinary tract infection (UTI) urgently via a suspected cancer pathway for specialist assessment within 2 weeks NICE CKS,NICE CKS,NICE NG12.
- Refer patients aged 45 years and over with visible hematuria that persists or recurs after successful treatment of UTI urgently via a suspected cancer pathway NICE CKS,NICE CKS,NICE CKS,NICE NG12.
- Refer patients aged 60 years and over with unexplained non-visible hematuria accompanied by dysuria or a raised white cell count on blood tests urgently via a suspected cancer pathway NICE CKS,NICE CKS,NICE CKS,NICE NG12.
- Initial investigations in primary care should include urine dipstick and microscopy to confirm hematuria and exclude infection, and urine culture if UTI is suspected NICE CKS.
- If UTI is present, treat appropriately and reassess; persistent or recurrent hematuria after treatment warrants urgent referral NICE CKS,NICE NG12.
- Do not rely on urinary biomarkers alone to exclude bladder cancer; cystoscopy remains the gold standard investigation for suspected bladder cancer NICE NG2.
- Specialist assessment typically includes cystoscopy and imaging such as CT urography to evaluate the bladder and upper urinary tract NICE NG2.
- Consider additional investigations such as blood tests and imaging based on clinical features and risk factors NICE NG12,NICE NG2.